United States · Wires & real time · PR Newswire

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Published by PR Newswire · United States 1 h ago

LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Business Wire

CrowdStrike Extends Anthropic’s Claude Cowork Enterprise AI Adoption with Falcon Guardian Protection

Associated Press (Business)

8 innovative gifts meant to change up how we drive, cook, sleep and more

Dow Jones Newswires

Rethinking AI in Enterprise Intelligence

MT Newswires

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

Share

Also worth reading

CrowdStrike Extends Anthropic’s Claude Cowork Enterprise AI Adoption with Falcon Guardian Protection

8 innovative gifts meant to change up how we drive, cook, sleep and more

Rethinking AI in Enterprise Intelligence

Global Financial News from MT Newswires Now Live in Microsoft Copilot